Cargando…

Development of antigen‐prediction algorithm for personalized neoantigen vaccine using human leukocyte antigen transgenic mouse

Immunotherapy is currently recognized as the fourth modality in cancer therapy. CTL can detect cancer cells via complexes involving human leukocyte antigen (HLA) class I molecules and peptides derived from tumor antigens, resulting in antigen‐specific cancer rejection. The peptides may be predicted...

Descripción completa

Detalles Bibliográficos
Autores principales:	Charneau, Jimmy, Suzuki, Toshihiro, Shimomura, Manami, Fujinami, Norihiro, Mishima, Yuji, Hiranuka, Kazushi, Watanabe, Noriko, Yamada, Takashi, Nakamura, Norihiro, Nakatsura, Tetsuya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	ORIGINAL ARTICLES
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8990807/ https://www.ncbi.nlm.nih.gov/pubmed/35122353 http://dx.doi.org/10.1111/cas.15291

Ejemplares similares

Peptide-Based Vaccines for Hepatocellular Carcinoma: A Review of Recent Advances
por: Charneau, Jimmy, et al.
Publicado: (2021)

‘Hotspots’ of Antigen Presentation Revealed by Human Leukocyte Antigen Ligandomics for Neoantigen Prioritization
por: Müller, Markus, et al.
Publicado: (2017)

Hepatocellular carcinoma cell sensitivity to Vγ9Vδ2 T lymphocyte-mediated killing is increased by zoledronate
por: SUGAI, SHIORI, et al.
Publicado: (2016)

Enhancement of antitumor effect by peptide vaccine therapy in combination with anti-CD4 antibody: Study in a murine model
por: Fujinami, Norihiro, et al.
Publicado: (2016)

Cancer immunotherapy‐targeted glypican‐3 or neoantigens
por: Shimizu, Yasuhiro, et al.
Publicado: (2018)

Intratumoral peptide injection enhances tumor cell antigenicity recognized by cytotoxic T lymphocytes: a potential option for improvement in antigen-specific cancer immunotherapy
por: Nobuoka, Daisuke, et al.
Publicado: (2012)

Usefulness of serum microRNA as a predictive marker of recurrence and prognosis in biliary tract cancer after radical surgery
por: Akazawa, Yu, et al.
Publicado: (2019)

A peptide antigen derived from EGFR T790M is immunogenic in non-small cell lung cancer
por: OFUJI, KAZUYA, et al.
Publicado: (2014)

Efficacy of immunotherapy targeting the neoantigen derived from epidermal growth factor receptor T790M/C797S mutation in non–small cell lung cancer
por: Akazawa, Yu, et al.
Publicado: (2020)

Higher human lymphocyte antigen class I expression in early‐stage cancer cells leads to high sensitivity for cytotoxic T lymphocytes
por: Akazawa, Yu, et al.
Publicado: (2019)

Immunological efficacy of glypican-3 peptide vaccine in patients with advanced hepatocellular carcinoma
por: Tsuchiya, Nobuhiro, et al.
Publicado: (2017)

Expression of a Chimeric Antigen Receptor in Multiple Leukocyte Lineages in Transgenic Mice
por: Yong, Carmen S. M., et al.
Publicado: (2015)

Antigen Presentation Profiling Reveals Recognition of Lymphoma Immunoglobulin Neoantigens
por: Khodadoust, M.S., et al.
Publicado: (2017)

Colorectal cancer vaccines: Tumor-associated antigens vs neoantigens
por: Wagner, Sandra, et al.
Publicado: (2018)

Usefulness of plasma full-length glypican-3 as a predictive marker of hepatocellular carcinoma recurrence after radial surgery
por: Miura, Masahiro, et al.
Publicado: (2020)

Generation of GM-CSF-producing antigen-presenting cells that induce a cytotoxic T cell-mediated antitumor response
por: Mashima, Hiroaki, et al.
Publicado: (2020)

T lymphocyte recognition of peptide antigens: evidence favoring the formation of neoantigenic determinants
Publicado: (1982)

Randomized study of teriflunomide effects on immune responses to neoantigen and recall antigens
por: Bar-Or, Amit, et al.
Publicado: (2015)

The Connection Between Minor H Antigens and Neoantigens and the Missing Link in Their Prediction
por: Mutis, Tuna, et al.
Publicado: (2020)

Structural engineering of chimeric antigen receptors targeting HLA-restricted neoantigens
por: Hwang, Michael S., et al.
Publicado: (2021)

Peptide vaccine as an adjuvant therapy for glypican‐3‐positive hepatocellular carcinoma induces peptide‐specific CTLs and improves long prognosis
por: Taniguchi, Masatake, et al.
Publicado: (2020)

Ki67 expression and localization of T cells after neoadjuvant therapies as reliable predictive markers in rectal cancer
por: Imaizumi, Ken, et al.
Publicado: (2019)

Phase I study of glypican-3-derived peptide vaccine therapy for patients with refractory pediatric solid tumors
por: Tsuchiya, Nobuhiro, et al.
Publicado: (2017)

Beyond Neoantigens: Antigens Derived from Tumor Drivers as Cancer Vaccine Targets
por: Crosby, Erika J., et al.
Publicado: (2023)

Time-lapse imaging assay using the BioStation CT: A sensitive drug-screening method for three-dimensional cell culture
por: Sakamoto, Ruriko, et al.
Publicado: (2015)

Identification of Novel HLA Class II-Restricted Neoantigens Derived from Driver Mutations
por: Iiizumi, Susumu, et al.
Publicado: (2019)

Programmed death-1 blockade enhances the antitumor effects of peptide vaccine-induced peptide-specific cytotoxic T lymphocytes
por: SAWADA, YU, et al.
Publicado: (2014)

Human Leukocyte Antigens in Pregnancy and Preeclampsia
por: Aisagbonhi, Omonigho, et al.
Publicado: (2022)

Evidence that the leukocyte-common antigen is required for antigen-induced T lymphocyte proliferation
por: Pingel, Jeanette T., et al.
Publicado: (1989)

Aberrant splicing isoforms detected by full-length transcriptome sequencing as transcripts of potential neoantigens in non-small cell lung cancer
por: Oka, Miho, et al.
Publicado: (2021)

Alanine-based spacers promote an efficient antigen processing and presentation in neoantigen polypeptide vaccines
por: Aguilar-Gurrieri, Carmen, et al.
Publicado: (2023)

Peptide intra-tumor injection for cancer immunotherapy: Enhancement of tumor cell antigenicity is a novel and attractive strategy
por: Nobuoka, Daisuke, et al.
Publicado: (2013)

Expression of classical human leukocyte antigen class I antigens, HLA‐E and HLA‐G, is adversely prognostic in pancreatic cancer patients
por: Hiraoka, Nobuyoshi, et al.
Publicado: (2020)

Importance of human leukocyte antigen antibodies and leukocyte antigen/killer-cell immunoglobulin-like receptor genes in liver transplantation
por: Muro, Manuel, et al.
Publicado: (2023)

Robust antigen-specific CD8 T cell tolerance to a model prostate cancer neoantigen
por: Lopez-Bujanda, Zoila A., et al.
Publicado: (2020)

Proteogenomic discovery of neoantigens facilitates personalized multi-antigen targeted T cell immunotherapy for brain tumors
por: Rivero-Hinojosa, Samuel, et al.
Publicado: (2021)

A Universal Antigen-Ranking Method to Design Personalized Vaccines Targeting Neoantigens against Melanoma
por: Malaina, Iker, et al.
Publicado: (2023)

Evolution and Diversity of the Human Leukocyte Antigen(HLA)
por: Markov, Peter V., et al.
Publicado: (2015)

A future without human leukocyte antigens?()
por: Gilli, Simone Cristina Olenscki
Publicado: (2018)

Sarcopenia and Variation in the Human Leukocyte Antigen Complex
por: Jones, Garan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_871n1f85912b1eps4e74epe4f6